Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatima Ferreira

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
International Archives of Allergy and Immunology|June 11, 2005
Can we predict or avoid the allergenic potential of genetically modified organisms?Gerhard Obermeyer, Fatima Ferreira
Biologie Aujourd'Hui|November 5, 2016
[Role and regulation of cAMP signaling in human trophoblast fusion]Pascale Gerbaud, Fatima Ferreira, Guillaume Pidoux
Immunotherapy|November 29, 2013
Recombinant allergens for pollen immunotherapyMichael Wallner, Ulrike Pichler, Fatima Ferreira
Methods (San Diego, Calif.)|June 29, 2013
Allergens of weed pollen: an overview on recombinant and natural moleculesGabriele Gadermaier, Michael Hauser, Fatima Ferreira
Yonsei Medical Journal|June 24, 2014
Molecular approach to allergy diagnosis and therapyFatima Ferreira, Martin Wolf, Michael Wallner
Handbook of Experimental Pharmacology|July 1, 2021
B Cell Functions in the Development of Type I Allergy and Induction of Immune ToleranceLisa Naomi Pointner, Fatima Ferreira, Lorenz Aglas
Allergy|May 25, 2019
Legends of Allergy and Immunology: From a curious mind to a world class scientist-A brief biography of Professor T.P. KingFatima Ferreira, Gudrun Hubinger, Michael D Spangfort
Clinical Allergy and Immunology|March 27, 2004
Modifying allergens and using adjuvants for specific immunotherapyMark Larché, Fatima Ferreira, Shyam S Mohapatra
Current Opinion in Molecular Therapeutics|April 27, 2007
Specific immunotherapy in pollen allergyMichael Wallner, Peter Briza, Josef Thalhamer, et al.
The Journal of Allergy and Clinical Immunology|September 19, 2003
TH1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies: no evidence for the synthesis of nonanaphylactic IgG1Romana Hochreiter, Fatima Ferreira, Josef Thalhamer, et al.
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
International Archives of Allergy and Immunology|June 11, 2005
Can we predict or avoid the allergenic potential of genetically modified organisms?Gerhard Obermeyer, Fatima Ferreira
Biologie Aujourd'Hui|November 5, 2016
[Role and regulation of cAMP signaling in human trophoblast fusion]Pascale Gerbaud, Fatima Ferreira, Guillaume Pidoux
Immunotherapy|November 29, 2013
Recombinant allergens for pollen immunotherapyMichael Wallner, Ulrike Pichler, Fatima Ferreira
Methods (San Diego, Calif.)|June 29, 2013
Allergens of weed pollen: an overview on recombinant and natural moleculesGabriele Gadermaier, Michael Hauser, Fatima Ferreira
Yonsei Medical Journal|June 24, 2014
Molecular approach to allergy diagnosis and therapyFatima Ferreira, Martin Wolf, Michael Wallner
Handbook of Experimental Pharmacology|July 1, 2021
B Cell Functions in the Development of Type I Allergy and Induction of Immune ToleranceLisa Naomi Pointner, Fatima Ferreira, Lorenz Aglas
Allergy|May 25, 2019
Legends of Allergy and Immunology: From a curious mind to a world class scientist-A brief biography of Professor T.P. KingFatima Ferreira, Gudrun Hubinger, Michael D Spangfort
Clinical Allergy and Immunology|March 27, 2004
Modifying allergens and using adjuvants for specific immunotherapyMark Larché, Fatima Ferreira, Shyam S Mohapatra
Current Opinion in Molecular Therapeutics|April 27, 2007
Specific immunotherapy in pollen allergyMichael Wallner, Peter Briza, Josef Thalhamer, et al.
The Journal of Allergy and Clinical Immunology|September 19, 2003
TH1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies: no evidence for the synthesis of nonanaphylactic IgG1Romana Hochreiter, Fatima Ferreira, Josef Thalhamer, et al.
Pageof 18